1. Home
  2. SNDX vs TV Comparison

SNDX vs TV Comparison

Compare SNDX & TV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • TV
  • Stock Information
  • Founded
  • SNDX 2005
  • TV 1969
  • Country
  • SNDX United States
  • TV Mexico
  • Employees
  • SNDX N/A
  • TV N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • TV Broadcasting
  • Sector
  • SNDX Health Care
  • TV Industrials
  • Exchange
  • SNDX Nasdaq
  • TV Nasdaq
  • Market Cap
  • SNDX 1.2B
  • TV 1.1B
  • IPO Year
  • SNDX 2016
  • TV 1993
  • Fundamental
  • Price
  • SNDX $14.34
  • TV $2.02
  • Analyst Decision
  • SNDX Strong Buy
  • TV Buy
  • Analyst Count
  • SNDX 10
  • TV 4
  • Target Price
  • SNDX $36.20
  • TV $5.57
  • AVG Volume (30 Days)
  • SNDX 2.1M
  • TV 2.6M
  • Earning Date
  • SNDX 02-25-2025
  • TV 02-20-2025
  • Dividend Yield
  • SNDX N/A
  • TV 27.45%
  • EPS Growth
  • SNDX N/A
  • TV N/A
  • EPS
  • SNDX N/A
  • TV N/A
  • Revenue
  • SNDX $16,000,000.00
  • TV $3,622,556,115.00
  • Revenue This Year
  • SNDX N/A
  • TV N/A
  • Revenue Next Year
  • SNDX N/A
  • TV N/A
  • P/E Ratio
  • SNDX N/A
  • TV N/A
  • Revenue Growth
  • SNDX N/A
  • TV 2.82
  • 52 Week Low
  • SNDX $12.06
  • TV $1.66
  • 52 Week High
  • SNDX $25.34
  • TV $3.65
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 54.69
  • TV 60.91
  • Support Level
  • SNDX $13.97
  • TV $1.82
  • Resistance Level
  • SNDX $13.16
  • TV $2.02
  • Average True Range (ATR)
  • SNDX 0.66
  • TV 0.09
  • MACD
  • SNDX 0.17
  • TV 0.03
  • Stochastic Oscillator
  • SNDX 85.39
  • TV 84.38

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About TV Grupo Televisa S.A.

Televisa is one of the leading telecommunication firms in Mexico. Its cable arm, Izzi, holds networks that pass nearly 20 million Mexican homes and provide broadband service to 6 million customers. The firm is also one of the largest pay-television providers in Mexico, with 4 million customers. Televisa holds a majority stake in Sky Mexico, the country's only satellite-TV provider, serving about 5 million customers. Televisa has agreed to buy AT&T's minority stake in Sky. After merging its traditional media business into Univision, Grupo Televisa owns a 45% stake in combined entity TelevisaUnivision. Grupo Televisa spun off several smaller businesses, including magazine publishing, three of Mexico's professional soccer teams, and Stadium Azteca in February 2024 under the name Ollamani.

Share on Social Networks: